Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Clin Gastroenterol Hepatol. 2022 Sep;20(9):2005-2013. doi: 10.1016/j.cgh.2021.09.026. Epub 2021 Sep 24.
BACKGROUND & AIMS: Chronic pancreatitis (CP) is associated with osteopathy (osteoporosis or osteopenia). However, existing literature is mostly limited to retrospective or administrative studies that have not clearly defined the prevalence and risk factors. Our aim was to identify patient- and disease-related associations with osteopathy in a prospective cohort study of CP.
We studied 282 subjects with definitive CP enrolled in the PROCEED study who had a baseline dual-energy X-ray absorptiometry (DXA) scan. Osteopenia and osteoporosis were defined using the lowest T-scores. Clinical data were collected using standardized case report forms. Comparisons were performed with a multivariate logistic regression model with forward selection to identify risk factors for osteopathy.
The majority of subjects had osteopathy on DXA scan (56.0%; 17.0% osteoporosis; 39.0% osteopenia). Subjects with osteopathy had a higher prevalence of traumatic (40.0% vs 26.4%; P = .02) and spontaneous fractures (3.9% vs 0; P = .04). On multivariate analysis, older age (odds ratio [OR], 1.29 per 5 years; 95% confidence interval [CI], 1.15-1.45), female sex (OR, 3.08; 95% CI, 1.75-5.43), white race (OR, 2.68; 95% CI, 1.20-6.01), and underweight body mass index category (OR, 7.40; 95% CI, 1.56-34.99) were associated with higher probability of osteopathy. There were no significant associations between osteopathy and other patient and disease-related features of CP.
In the largest study of patients with CP who underwent DXA screening, the majority had osteopathy. There are overlapping risk factors with osteopathy in the general population, but the high prevalence in men and younger women supports the need for future investigations into the mechanisms of bone loss in CP.
gov number, NCT03099850.
慢性胰腺炎(CP)与骨病(骨质疏松或骨量减少)有关。然而,现有文献大多局限于回顾性或行政研究,并未明确界定其患病率和危险因素。本研究旨在通过一项 CP 前瞻性队列研究,确定与骨病相关的患者和疾病相关因素。
我们研究了 282 名确诊为 CP 的 PROCEED 研究患者,他们在基线时进行了双能 X 线吸收法(DXA)扫描。骨质疏松症和骨量减少分别使用最低 T 评分来定义。使用标准化病例报告表收集临床数据。采用逐步向前选择的多变量逻辑回归模型进行比较,以确定骨病的危险因素。
大多数患者 DXA 扫描结果显示存在骨病(56.0%;骨质疏松症 17.0%;骨量减少 39.0%)。骨病患者创伤性(40.0%比 26.4%;P=0.02)和自发性骨折(3.9%比 0;P=0.04)的发生率更高。多变量分析显示,年龄较大(每增加 5 岁,比值比 [OR] 1.29;95%置信区间 [CI] 1.15-1.45)、女性(OR 3.08;95% CI 1.75-5.43)、白种人(OR 2.68;95% CI 1.20-6.01)和体重指数较低(OR 7.40;95% CI 1.56-34.99)与骨病的发生概率较高相关。骨病与 CP 的其他患者和疾病相关特征之间无显著相关性。
在最大的 CP 患者 DXA 筛查研究中,大多数患者存在骨病。与一般人群中的骨病存在重叠的危险因素,但男性和年轻女性的高患病率支持进一步研究 CP 中骨丢失的机制。
gov 编号,NCT03099850。